Salvage therapy for children with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28084041)

Published in Pediatr Blood Cancer on January 13, 2017

Authors

Yuichi Kodama1,2, Atsushi Manabe3, Hirohide Kawasaki4, Itaru Kato5, Keisuke Kato6, Atsushi Sato7, Kimikazu Matsumoto8, Motohiro Kato8, Hidefumi Hiramatsu5, Hideki Sano9, Takashi Kaneko10, Megumi Oda11, Akiko M Saito2, Souichi Adachi12, Keizo Horibe2, Shuki Mizutani13, Eiichi Ishii14, Hiroyuki Shimada15

Author Affiliations

1: Department of Pediatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
2: Clinical Research Center, National Hospital Organization Nagoya Medical Center, Aichi, Japan.
3: Department of Pediatrics, St. Luke's International Hospital, Tokyo, Japan.
4: Department of Pediatrics, Kansai Medical University Hirakata Hospital, Osaka, Japan.
5: Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
6: Department of Pediatric Hematology and Oncology, Ibaraki Children's Hospital, Mito, Japan.
7: Department of Hematology and Oncology, Miyagi Children's Hospital, Miyagi, Japan.
8: Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan.
9: Department of Pediatric Oncology, Fukushima Medical University Hospital, Fukushima, Japan.
10: Department of Hematology and Oncology, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.
11: Department of Pediatric Hematology and Oncology, Okayama University Hospital, Okayama, Japan.
12: Human Health Sciences, Kyoto University, Kyoto, Japan.
13: Department of Pediatrics, Tokyo Medical and Dental University, Tokyo, Japan.
14: Department of Pediatrics, Ehime University Graduate School of Medicine, Ehime, Japan.
15: Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan.

Articles by these authors

A Cytokine-Based Diagnostic Program in Pediatric Aplastic Anemia and Hypocellular Refractory Cytopenia of Childhood. Pediatr Blood Cancer (2015) 1.38

NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity. Nat Genet (2016) 0.93

First case of aplastic anemia in a Japanese child with a homozygous missense mutation in the NBS1 gene (I171V) associated with genomic instability. Hum Genet (2004) 0.92

Leukostasis in Children and Adolescents with Chronic Myeloid Leukemia: Japanese Pediatric Leukemia/Lymphoma Study Group. Pediatr Blood Cancer (2015) 0.83

Imatinib use immediately before stem cell transplantation in children with Philadelphia chromosome-positive acute lymphoblastic leukemia: Results from Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) Study Ph(+) ALL04. Cancer Med (2015) 0.80

Clinical Usefulness of Serum Krebs von den Lungen-6 for Detecting Chronic Aspiration in Children with Severe Motor and Intellectual Disabilities. J Pediatr (2015) 0.79

Criteria for evaluating response and outcome in clinical trials for children with juvenile myelomonocytic leukemia. Haematologica (2015) 0.78

Clinical utility of next-generation sequencing for inherited bone marrow failure syndromes. Genet Med (2017) 0.78

Preserved High Probability of Overall Survival with Significant Reduction of Chemotherapy for Myeloid Leukemia in Down Syndrome: A Nationwide Prospective Study in Japan. Pediatr Blood Cancer (2015) 0.77

Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia treatment: a Delphi consensus. Lancet Oncol (2016) 0.77

Acute myeloid leukemia in children: Current status and future directions. Pediatr Int (2016) 0.77

Recurrent SPI1 (PU.1) fusions in high-risk pediatric T cell acute lymphoblastic leukemia. Nat Genet (2017) 0.77

Successful reduced-intensity stem cell transplantation for GATA2 deficiency before progression of advanced MDS. Pediatr Transplant (2016) 0.76

Specific Antileukemic Activity of PD0332991, a CDK4/6 Inhibitor, against Philadelphia Chromosome-Positive Lymphoid Leukemia. Mol Cancer Ther (2015) 0.76

Diagnostic accuracy of endoscopic features of pediatric acute gastrointestinal graft-versus-host disease. Dig Endosc (2016) 0.75

Pediatric thromboembolism: a national survey in Japan. Int J Hematol (2016) 0.75

Impact of pretransplant minimal residual disease on the post-transplant outcome of pediatric acute lymphoblastic leukemia. Pediatr Transplant (2016) 0.75

Haploidentical stem cell transplantation with posttransplant cyclophosphamide for refractory systemic juvenile xanthogranuloma. Pediatr Blood Cancer (2019) 0.75

Testicular involvement without testicular enlargement in a young male with atypical chronic myeloid leukemia. Pediatr Blood Cancer (2019) 0.75

A prospective study of allogeneic hematopoietic stem cell transplantation with post-transplantation cyclophosphamide and anti-thymoglobulin from HLA-mismatched related donors for non-malignant diseases. Biol Blood Marrow Transplant (2020) 0.75

Flow cytometric analysis as an additional predictive tool of treatment response in children with chronic-phase chronic myeloid leukemia treated with imatinib. Pediatr Blood Cancer (2017) 0.75

Pneumorrhachis in children: A report of two cases and review of the literature. Radiol Case Rep (2019) 0.75

Very late relapse cases of TCF3-ZNF384-positive acute lymphoblastic leukemia. Pediatr Blood Cancer (2019) 0.75

Acanthosis nigricans in a Japanese boy with hypochondroplasia due to a K650T mutation in FGFR3. Clin Pediatr Endocrinol (2017) 0.75

Pediatric intestinal Behçet disease complicated by myeloid malignancies. Int J Hematol (2016) 0.75

A nationwide survey of hypoplastic myelodysplastic syndrome (a multicenter retrospective study). Am J Hematol (2017) 0.75

Retrospective analysis of children with high-risk acute myeloid leukemia who underwent allogeneic hematopoietic stem cell transplantation following complete remission with initial induction chemotherapy in the AML-05 clinical trial. Pediatr Blood Cancer (2019) 0.75

Monitoring of fusion gene transcripts to predict relapses in pediatric acute myeloid leukemia. Pediatr Int (2017) 0.75

Severe hypertriglyceridemia during treatment of acute lymphoblastic leukemia associated with type III hyperlipoproteinemia. Pediatr Blood Cancer (2017) 0.75

Pazopanib for second recurrence of osteosarcoma in pediatric patients. Pediatr Int (2017) 0.75

Impact of post-transplant minimal residual disease on the clinical outcome of pediatric acute leukemia. Pediatr Transplant (2017) 0.75

Cancer in adolescents and young adults: National incidence and characteristics in Japan. Cancer Epidemiol (2017) 0.75

ASXL2 Mutations are Frequently Found in Pediatric AML Patients with t(8;21)/RUNX1-RUNX1T1 and Associated with a Better Prognosis. Genes Chromosomes Cancer (2017) 0.75

Residual disease detected by multidimensional flow cytometry shows prognostic significance in childhood acute myeloid leukemia with intermediate cytogenetics and negative FLT3-ITD: a report from the Tokyo Children's Cancer Study Group. Int J Hematol (2016) 0.75

Persistent clonal chromosomal abnormalities in a chronic myeloid leukemia patient. Pediatr Int (2015) 0.75

Transmission of chromosomally integrated human herpesvirus 6 via cord blood transplantation. Transpl Infect Dis (2016) 0.75

Phase I study of perifosine monotherapy in patients with recurrent or refractory neuroblastoma. Pediatr Blood Cancer (2017) 0.75

Hematopoietic Cell Transplantation for Chronic Granulomatous Disease in Japan. Front Immunol (2020) 0.75

Bortezomib combined with standard induction chemotherapy in Japanese children with refractory acute lymphoblastic leukemia. Int J Hematol (2017) 0.75

Comparison of Donor Sources in Hematopoietic Stem Cell Transplantation for Childhood Acute Leukemia: A Nationwide Retrospective Study. Biol Blood Marrow Transplant (2016) 0.75

Prognostic value of genetic mutations in adolescent and young adults with acute myeloid leukemia. Int J Hematol (2017) 0.75

Comparison of transplantation with reduced and myeloablative conditioning for children with acute lymphoblastic leukemia. Blood (2015) 0.75

Constitutional abnormalities of IDH1 combined with secondary mutations predispose a patient with Maffucci syndrome to acute lymphoblastic leukemia. Pediatr Blood Cancer (2017) 0.75

Respiratory syncytial virus infection in infants with acute leukemia: a retrospective survey of the Japanese Pediatric Leukemia/Lymphoma Study Group. Int J Hematol (2015) 0.75

Secondary cancers after a childhood cancer diagnosis: a nationwide hospital-based retrospective cohort study in Japan. Int J Clin Oncol (2015) 0.75

Efficacy and safety of oral propranolol for infantile hemangioma in Japan. Pediatr Int (2017) 0.75

Anal Canal Carcinoma in a Child With Disorders of Sex Development. Pediatr Blood Cancer (2016) 0.75

Successful treatment of refractory donor lymphocyte infusion-induced immune-mediated pancytopenia with rituximab. Pediatr Blood Cancer (2010) 0.75

T-cell-rich HLA-haploidentical hematopoietic stem cell transplantation for relapsed/refractory pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia without posttransplant tyrosine kinase inhibitor therapy. Pediatr Blood Cancer (2016) 0.75

A randomized phase II study to assess the effect of adjuvant immunotherapy using α-GalCer-pulsed dendritic cells in the patients with completely resected stage II-IIIA non-small cell lung cancer: study protocol for a randomized controlled trial. Trials (2017) 0.75

Hypoxic adaptation of leukemic cells infiltrating the CNS affords a therapeutic strategy targeting VEGF. Blood (2017) 0.75

T cell replete-haploidentical second hematopoietic stem cell transplantation for primary graft failure in pediatric patients with hematologic malignancies. Pediatr Transplant (2017) 0.75

A Pediatric Case of Metastatic Conventional Parosteal Osteosarcoma Treated With Multidrug Chemotherapy. Pediatr Blood Cancer (2016) 0.75

Favorable outcome in non-infant children with MLL-AF4-positive acute lymphoblastic leukemia: a report from the Tokyo Children's Cancer Study Group. Int J Hematol (2015) 0.75

Direct Delivery of CD19 CAR T Cells Has Potent Anti-tumor Activity against ALL Cells in CNS in a Xenograft Mouse Model. Mol Ther Oncolytics (2020) 0.75

The incidence of symptomatic osteonecrosis is similar between Japanese children and children in Western countries with acute lymphoblastic leukaemia treated with a Berlin-Frankfurt-Münster (BFM)95-based protocol. Br J Haematol (2021) 0.75